| A computational solution for bolstering reliability of epigenetic clocks: Implications for clinical trials and longitudinal tracking AT Higgins-Chen, KL Thrush, Y Wang, CJ Minteer, PL Kuo, M Wang, ... Nature aging 2 (7), 644-661, 2022 | 141 | 2022 |
| Polygenic risk scores for genetic counseling in psychiatry: lessons learned from other fields of medicine E Eeltink, MZ Van der Horst, JR Zinkstok, CM Aalfs, JJ Luykx Neuroscience & Biobehavioral Reviews 121, 119-127, 2021 | 23 | 2021 |
| Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders C Okhuijsen-Pfeifer, MZ van der Horst, CA Bousman, B Lin, KR van Eijk, ... Translational Psychiatry 12 (1), 145, 2022 | 20 | 2022 |
| Impact of the first COVID-19 outbreak on mental health service utilisation at a Dutch mental health centre: retrospective observational study MW Chow, EO Noorthoorn, AI Wierdsma, M Van Der Horst, N De Boer, ... BJPsych open 7 (6), e213, 2021 | 14 | 2021 |
| Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians’ attitudes to sociocultural differences between patients across the globe J Pinzón-Espinosa, M van der Horst, J Zinkstok, J Austin, C Aalfs, ... Translational Psychiatry 12 (1), 442, 2022 | 11 | 2022 |
| Associations between polygenic risk score loading, psychosis liability, and clozapine use among individuals with schizophrenia BD Lin, J Pinzón-Espinosa, E Blouzard, MZ van der Horst, ... JAMA psychiatry 80 (2), 181-185, 2023 | 9 | 2023 |
| Lifestyle interventions for people with a severe mental illness living in supported housing: A systematic review and meta-analysis LEM Koomen, MZ van der Horst, J Deenik, W Cahn Frontiers in Psychiatry 13, 966029, 2022 | 9 | 2022 |
| An international research agenda for clozapine-resistant schizophrenia JJ Luykx, JM Gonzalez-Diaz, TW Guu, MZ van der Horst, E van Dellen, ... The Lancet Psychiatry, 2023 | 6 | 2023 |
| Genetic determinants associated with response to clozapine in schizophrenia: an umbrella review MZ van Der Horst, G Papadimitriou, JJ Luykx Psychiatric Genetics 32 (5), 163-170, 2022 | 3 | 2022 |
| Isolated nausea and vomiting as the cardinal presenting symptoms of clozapine-induced myocarditis: a case report MZ Van Der Horst, F Van Houwelingen, JJ Luykx BMC psychiatry 20, 1-5, 2020 | 3 | 2020 |
| Polygenetic risk scores and phenotypic constellations of obsessive–compulsive disorder in clozapine-treated schizophrenia CL Morgenroth, P Kleymann, S Ripke, S Awasthi, E Wagner, ... European archives of psychiatry and clinical neuroscience 274 (1), 181-193, 2024 | 1 | 2024 |
| Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions MZ van der Horst, Y Meijer, N de Boer, S Guloksuz, A Hasan, D Siskind, ... Psychiatry Research 330, 115539, 2023 | 1 | 2023 |
| Genetisch risico van psychiatrische ziekten: wat weten we en hoe communiceren we dat? JR Zinkstok, MZ Van Der Horst, RPH Wouters, CM Aalfs, JJ Luykx Tijdschrift voor Psychiatrie, 266-272, 2022 | 1 | 2022 |
| Genetic risk of mental illness: what do we know and how do we communicate this? JR Zinkstok, MZ van der Horst, RPH Wouters, CM Aalfs, JJ Luykx Tijdschrift Voor Psychiatrie 64 (5), 266-272, 2022 | 1 | 2022 |
| Validation of the Dutch Glasgow Anti-psychotic Side-Effect Scale for Clozapine R Huisman, C Okhuijsen-Pfeifer, EYH Mulder, A Jongkind, D Cohen, ... Tijdschrift Voor Psychiatrie 63 (4), 270-275, 2021 | 1 | 2021 |
| The ethics of polygenic scores in psychiatry: minefield or opportunity for patient-centered psychiatry? RHP Wouters, MZ van der Horst, CM Aalfs, J Bralten, JJ Luykx, ... Psychiatric Genetics 34 (2), 31-36, 2024 | | 2024 |
| Op naar een gepersonaliseerde clozapinebehandeling C Okhuijsen-Pfeifer, MZ van der Horst, JJ Luykx Tijdschrift voor Psychiatrie, 107-112, 2023 | | 2023 |
| Towards personalized treatment with clozapine C Okhuijsen-Pfeifer, MZ van der Horst, JJ Luykx Tijdschrift Voor Psychiatrie 65 (2), 107-112, 2023 | | 2023 |
| Longitudinal changes in DNA methylation associated with clozapine use in treatment-resistant schizophrenia from two international cohorts A Gillespie, EM Walker, E Hannon, G McQueen, KV Sendt, A Avila, J Lally, ... medRxiv, 2023.11. 17.23298669, 2023 | | 2023 |
| Associations between polygenic risk score loading, psychosis liability, and clozapine use among individuals with schizophrenia JJ Luykx, JE Pinzón-Espinosa, E Blouzard, M van der Horst, ... | | 2022 |
Janneke ZinkstokStaff Psychiatrist, Radboud University Medical Center, NijmegenVerified email at radboudumc.nl
